Kinled Holding

Xapien is a company that specializes in automating online research through the use of artificial intelligence and natural language processing. Its platform is designed to assist in third-party risk management by delivering on-demand research on individuals and companies worldwide. By leveraging extensive cloud computing capabilities, Xapien enables clients to build efficient internal research capacities that provide deep contextual insights. This approach not only enhances decision-making but also reduces costs associated with internal and outsourced research efforts.

Connect Earth, founded in 2021 and based in London, is an environmental data company focused on providing accessible sustainability information. The company specializes in carbon tracking API technology, which allows users to understand the environmental impact of their daily spending. By standardizing carbon emissions data and calculating carbon footprints, Connect Earth empowers individuals and businesses to make informed, sustainable choices. Its API toolkit integrates sustainability insights into financial products, enabling financial institutions to offer customers transparent views of their climate impact. Through this approach, Connect Earth aims to bridge the gap between intent, knowledge, and action, fostering a culture of sustainable finance.

OneTrust, LLC is a technology company that specializes in privacy management and compliance solutions, assisting organizations in adhering to global regulations. Founded in 2016 and headquartered in Atlanta, Georgia, OneTrust offers a comprehensive platform that automates privacy impact assessments, data inventory mapping, and risk remediation actions. Its solutions cover a wide range of needs, including vendor risk management, incident reporting, and website compliance, helping businesses manage privacy risks associated with customer, employee, and vendor data. The platform enables collaboration among privacy professionals and business groups, facilitating continuous compliance through recurring audits and assessments. OneTrust serves a diverse clientele, from multinational corporations to small and medium enterprises, and operates additional offices in various global locations, including London, São Paulo, and Bengaluru.

Nanoflex Robotics is a MedTech startup established in 2021 that focuses on developing a telerobotic platform for remote Mechanical Thrombectomy, aimed at treating ischemic strokes. The company's innovative technology facilitates quicker remote treatments, which can improve patient outcomes and enhance health equity. Additionally, it offers benefits to hospitals by potentially increasing profitability. Nanoflex Robotics has received positive feedback from notable clinical partners, including the Jacobs Institute, Mayo Clinic, and Toronto Health. The firm has also created a proprietary soft robotic system designed to navigate complex vascular anatomy using precise electromagnetic fields, enabling physicians to effectively diagnose and treat vascular diseases such as acute ischemic stroke.

Hi.health is a company focused on transforming the claims process in private health insurance by addressing inefficiencies and enhancing user experience. It offers a health insurance application that integrates secure payment methods with a range of digital services, including invoice and prescription management. By providing co-branded debit cards to insurers' members, Hi.health eliminates out-of-pocket expenses, allowing users to access health-related facilities globally. The platform delivers real-time data, reducing claims lag and operational costs while minimizing fraud. Additionally, it implements a rewards program to encourage cost-effective behavior among users. Ultimately, Hi.health aims to significantly improve the user experience for insurance members while helping insurers achieve substantial cost savings.

Algonist Biotechnologies is a pre-clinical stage biotechnology company focused on developing innovative small molecule therapeutics for chronic and neuropathic pain. The company's approach centers on creating non-opioid drugs that aim to provide effective pain relief while minimizing the serious side effects commonly associated with existing treatments. By specializing in oral small-molecule therapeutics, Algonist Biotechnologies strives to enhance treatment efficacy and ensure patient safety, allowing individuals to alleviate chronic pain without harming neurons in the peripheral and central nervous systems.

Cebina Bridge Capital is a venture capital investment firm established in 2021 and based in Gibraltar. The firm specializes in investing in pharmaceutical drug discovery and biotechnology projects, particularly within Central and Eastern Europe. By targeting this specific geographical area and sector, Cebina Bridge Capital aims to support and advance innovative health solutions and technologies, fostering growth in the regional biotech landscape.

Five Lives is a London-based digital therapeutics company focused on enhancing cognitive health through its innovative mobile app, Sharp. This platform is designed to help users measure and mitigate their risk of cognitive decline by promoting healthier lifestyle choices. By offering an engaging and user-friendly tool, Five Lives aims to facilitate earlier detection of dementia and empower individuals to take proactive steps in maintaining their brain health. The company’s mission is to enable users to lead longer, healthier, and more fulfilling lives by improving their overall cognitive well-being.

Master your emotions in 5 minutes a day. Ahead is a personalized pocket coach that provides bite-sized, science-driven tools to boost emotional intelligence. Think of it as a pocket cheerleader towards a better, more fulfilling, clearer-minded way of life. Most of us continuously set goals for our life - for our career, our relationships, our health. Yet, it’s damn hard to turn those goals into reality! We know - we’ve been there ourselves. That’s why we know there’s a way to make it work. And that’s what aHead is all about! Get early access: ahead-app.com

PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers to increase the success rates in cancer therapy. Only an efficient use of healthcare resources can lead to a maximum improvement in the quality of life of patients.

Tridek-One is a biotechnology company focused on developing immunomodulatory products aimed at treating autoimmune diseases and inflammatory disorders. The company has created a peptide that preserves a cluster of truncated CD31 molecules at the membrane, allowing for the moderation of overactive immune responses without complete blockade. This innovative approach enables medical companies to provide enhanced therapeutic options, ultimately improving patient outcomes and quality of life.

OctaiPipe is a technology company that specializes in Federated Learning Operations (FL-Ops) specifically designed for Edge AIoT devices. Its architecture streamlines the entire lifecycle of AI model development, encompassing setup, training, deployment, fine-tuning, and continuous learning. By facilitating the creation of distributed IoT solutions, OctaiPipe empowers data scientists to develop systems that learn and adapt efficiently at scale. This approach not only enhances the operational effectiveness of critical infrastructure but also promotes sustainability, resilience, and security in a globally connected environment. Furthermore, OctaiPipe's solutions significantly reduce the costs associated with monitoring, maintenance, upgrades, and auditing, making it easier for organizations to manage their AI systems.

Accelus is committed to accelerating minimally invasive spine surgery through its procedure-enabling technology with broad accessibility to previously underserved markets.

Adsum is a London-based fintech company founded in 2020 that focuses on providing instant value-added tax (VAT) refunds and tax credits for businesses in the UK. The company offers a software solution that streamlines the VAT refund process through embedded software integrations with partner organizations. By leveraging artificial intelligence and machine learning, Adsum aims to simplify the tax credit process, reduce human error, and support business growth. With its innovative approach, Adsum seeks to enhance the financial efficiency of its clients by facilitating quick access to tax benefits.

BVNK offers a modern payment infrastructure that integrates traditional banking and blockchain technology on a single platform. The company enables businesses to send and receive stablecoin payments, convert between different currencies, and incorporate cryptocurrency payments into their checkout processes. BVNK's flexible platform is supported by extensive global licensing and compliance expertise, allowing innovators to swiftly and effectively launch new payment products. Additionally, BVNK provides a customizable banking system that combines a shared core with unique modules tailored to each client's needs, helping them reduce costs, enhance flexibility, and modernize their banking operations.

Engimmune Therapeutics is a platform and product development company using cutting-edge technologies in the life sciences engineering highly potent and specific therapies based on T cell receptors (TCR) targeting solid tumors.

Memo Therapeutics AG, based in Basel, Switzerland, specializes in innovative antibody discovery and immune repertoire analysis. The company utilizes its proprietary MemoMAB platform, which generates a recombinant in vitro copy of an individual's B cell or antibody repertoire, creating extensive libraries that represent unique immune responses. These libraries are expected to contain a vast array of relevant and rare antibodies, opening new avenues for immune repertoire analysis and antibody discovery. Memo Therapeutics applies this technology in its own antibody lead discovery programs and partners with other entities to enhance research and development in the fields of viral infections and cancer. Through its advancements, Memo Therapeutics aims to significantly improve therapeutic options for patients.

Wiredirect is a global financial technology and FX liquidity firm that has built a whole new way to make payments across borders.

Opal is a leading screen time management application designed to help users regain control over their phone usage and improve focus. The app combines features such as app restrictions, real-time feedback, and reward systems to assist individuals in minimizing distractions and enhancing productivity. It is utilized by over 200,000 users, including teams from startups and Fortune 500 companies, all of whom rely on Opal to protect their time. The application also offers tools for tracking saved time and disconnecting from distracting applications, ultimately aiming to support mental well-being and help users achieve their goals. With a mission to assist one billion people in focusing better daily, Opal is committed to fostering a more productive and fulfilling life for its users.

CEBINA uniquely supports life science entrepreneurs and early-stage start-up companies and develops cutting-edge biotech projects.

Lapse is a social disposable camera application that allows users to capture and share photos in a nostalgic format reminiscent of traditional disposable cameras. The app facilitates private group chats where users can take up to 36 snapshots, creating a "roll" that is only accessible to group members for a limited time after the first image is taken. This design encourages spontaneity and a sense of shared experience among friends, promoting an engaging way to document moments together while maintaining privacy.

Acrivon Therapeutics is a clinical-stage biopharmaceutical company focused on precision oncology, developing therapeutics that target challenging cancer types without straightforward single-gene mutations. The company employs a proteomics-based platform to identify patients whose tumors are likely to respond to specific treatments. Acrivon's pipeline includes ACR-368, also known as prexasertib, which is currently in Phase 2 trials, alongside preclinical programs aimed at key components of DNA damage response and cell cycle regulation, such as the WEE1 and PKMYT1 proteins. Acrivon seeks to expedite the development of both in-licensed clinical-stage assets and its internally developed programs through accelerated registration trials, aiming to enhance treatment success in oncology.

Cobee is a Madrid-based company founded in 2018 that specializes in automating and simplifying employee benefits management. Its online platform allows businesses to streamline the administration of employee benefits and flexible compensation. Cobee provides each employee with a VISA card linked to a digital application, enabling them to pay for various expenses such as meals, transportation, daycare, training, and medical insurance. This approach not only enhances employee satisfaction but also reduces costs for companies by eliminating intermediaries and external suppliers. The platform centralizes information, improving the management and visibility of benefits, while also offering real-time insights into savings. Cobee aims to create a seamless experience for both employers and employees, allowing organizations to focus on their core operations.

FERNRIDE provides automation solutions for yard trucking that enhance productivity, sustainability, and worker safety. The company employs a human-assisted autonomy approach, allowing for remote control of trucks when necessary, which facilitates reliable operations for logistics operators. With over a decade of research and partnerships with notable clients such as Volkswagen, HHLA, and DB Schenker, FERNRIDE leverages advanced technology to tackle pressing industry issues, including driver shortages and the environmental impact of logistics. The company specializes in an autonomous, electric trucking platform that integrates teleoperations and autonomous driving technologies, enabling logistics service providers to efficiently deploy yard trucks in productive operations. Founded by Hendrik Kramer, Maximilian Fisser, and Jean-Michael Georg, FERNRIDE has grown to employ over 150 individuals.

Alentis Therapeutics AG is a clinical-stage biopharmaceutical company based in Basel, Switzerland, focused on developing innovative therapies for advanced liver diseases, including liver fibrosis, cirrhosis, and liver cancer. Established in 2019, Alentis is recognized for its pioneering work in targeting CLDN1+ cancers through the use of anti-CLDN1 antibody-drug conjugates and other therapeutic modalities. The company's research platform incorporates clinically relevant read-outs and single-cell RNA sequencing of patient liver tissues, which aids in understanding and treating fibrotic diseases. Alentis aims to modify and reverse disease progression, ultimately addressing significant health challenges associated with liver-related conditions.

Hummingbird Bioscience focuses on the development of innovative therapeutic antibody-based drugs aimed at addressing significant unmet needs in oncology and immuno-oncology. Utilizing a proprietary rational antibody discovery platform, the company leverages systems biology and computational methods to gain insights into disease mechanisms, guiding the discovery and engineering of new biotherapeutics. Hummingbird's pipeline includes promising drug candidates such as HMBD-001, an anti-HER3 antibody, and HMBD-002, an anti-VISTA antibody, both targeting cancer treatment. The company has formed strategic collaborations with organizations like Cancer Research UK and Amgen and has received a product development grant from the Cancer Prevention and Research Institute of Texas. This collaborative approach enhances Hummingbird's capacity to deliver effective therapies for patients with challenging medical conditions.

Sylvera is a carbon data provider based in London, United Kingdom, established in 2020. The company specializes in developing machine learning-based tools to monitor the performance of carbon offset projects. These tools enable remote tracking of project performance at intervals of up to a week, facilitating the integration of carbon data into both internal and external reporting frameworks. By offering enhanced transparency around carbon offsets, Sylvera aims to assist businesses and governments in reducing reputational risks associated with carbon emissions, ultimately promoting real-world climate action.

Receeve is a customizable online platform designed for collections and recovery, aimed at simplifying the complexities of data and systems involved in credit management. The platform enables in-house teams to automate processes, engage customers, and leverage comprehensive insights to enhance debt recovery while minimizing risks. It supports all stages of credit management, from pre-delinquency to portfolio assignment and sale. Receeve's cloud-native, no-code solution is designed for quick deployment and easy management, allowing users to customize and expand functionalities as needed. By integrating intelligence, strategy, and operations into a single platform, receeve aims to improve operational effectiveness and transparency in debt servicing for companies, financial institutions, and funds of various sizes.

PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers to increase the success rates in cancer therapy. Only an efficient use of healthcare resources can lead to a maximum improvement in the quality of life of patients.

Gitpod is an open-source developer platform that automates the provisioning of ready-to-code development environments, enhancing productivity for engineering teams. By eliminating the need for manual setup of local development environments, Gitpod allows teams to save significant time and fosters improved collaboration in application development. The platform integrates seamlessly with popular version control services like GitLab, GitHub, and Bitbucket, automatically prebuilding development environments for all project branches. This functionality enables team members to begin coding immediately, whether they are developing new features, addressing bugs, or conducting code reviews. Gitpod's focus on automating setups allows developers to concentrate on their work, streamlining workflows and improving overall efficiency.

Bob W is a technology-driven hospitality provider that provides an alternative to hotels and short-stay apartments. Its exceptionally cool apartments cater to the 21st-century traveler who wants it all: the consistent quality of a hotel and the authentic flair and affordability of a short-stay rental. It combines both worlds in sustainably operated properties, which are currently available in Finland and Estonia but are expanding across Europe and beyond. The company was founded in 2018 and is headquartered in Helsinki, Finland.

Eirion Therapeutics is a clinical-stage biopharmaceutical company that is developing next-generation prescription products for aesthetic dermatology. The company currently has a rich pipeline of products focusing on treatments for wrinkles, primary axillary hyperhidrosis, androgenic alopecia, and hair greying. In the future, Eirion plans to also pursue additional indications that address other major unmet clinical needs for physicians and their patients.

Muse Finance operates a technology platform that connects businesses with working capital solutions, enhancing the financial experience for B2B clients. The platform offers a no-code and API integration, allowing brands to quickly implement white-label finance services. Muse Finance provides a scalable solution for finance companies to effectively manage risk and streamline the funding process. Its real-time dashboard enables businesses to oversee client funding requests and track their progress. The platform features advanced tools for cash flow forecasting and credit insights, facilitating instant credit decisions. Muse Finance offers three primary products: trade finance, buy now pay later for businesses, and invoice finance tailored for UK limited companies. Through these services, Muse Finance aims to empower small businesses with efficient fund management and future financial planning.

Cofenster specializes in automating video production through its innovative suite of Video AI assistants. These tools, designed to enhance the efficiency of Communication, HR, and Marketing teams, enable the creation of professional videos with minimal human intervention. Notable assistants include Milo, which transforms lengthy videos into engaging short clips; Ella, which generates authentic user-generated content; and Theo, which converts text into video format. Cofenster also offers a mobile application that streamlines the entire video creation process, allowing users to plan, record, and edit videos while incorporating subtitles, music, and corporate branding elements. The company serves a diverse clientele, including prominent corporations like TUI, Rewe Group, Siemens, Beiersdorf, and Vorwerk, as well as small and medium-sized enterprises.

Herophilus is engaged in the development of neurotherapeutics aimed at finding new treatments for brain disorders. The company leverages advanced technologies that combine human brain models, scaled biology, and machine learning to systematically discover and develop novel drugs with potential therapeutic applications. By employing phenotypic screening, Herophilus focuses on identifying innovative treatments for complex neurological and psychiatric conditions, including epilepsy, autism, and schizophrenia. This approach aims to enhance the ability of healthcare professionals to treat patients suffering from these brain diseases and to address the emotional symptoms associated with various neurological challenges.

HomeHero is a digital home management platform that simplifies the management of household tasks and expenses. The company offers a cloud-based system that integrates mobile and IoT technologies to streamline various services. Users can manage utility bills, household chores, and home repairs all in one place, allowing for efficient handling of maintenance issues, booking cleaners, and managing administrative tasks such as receiving packages or granting access to contractors. By providing access to online experts for live chat support, HomeHero aims to save users both time and money with a comprehensive solution for home management.

Primer is the unified infrastructure for global payments and commerce. With unrivaled freedom and visibility across the payments and commerce ecosystem, Primer equips merchants with the tools to effortlessly optimize performance, build at pace, and capture untapped revenue to achieve unstoppable growth. Primer operates in over 35 countries and serves category leaders in retail & e-commerce, travel & mobility, ticketing, and fintech. It has raised over US$74M, backed by Silicon Valley heavyweights Iconiq, Accel, Balderton, and RTP Global.

Greyparrot is a leader in AI waste analytics, focusing on enhancing recycling efforts and minimizing waste sent to landfills and incinerators. The company offers a waste intelligence platform that provides real-time insights into over 89 waste categories, analyzing data related to financial value, brand, and greenhouse gas emissions across various locations in recycling facilities. In 2024, Greyparrot processed data from over 40 billion waste objects, significantly improving operational efficiency and enabling facilities to save substantial amounts of money while diverting millions of tonnes of waste. The insights generated by Greyparrot assist recycling professionals, plant builders, packaging producers, and fast-moving consumer goods brands in enhancing recycling efficiency, adhering to regulations, and refining recyclable packaging design. Recognized for its innovative contributions, Greyparrot has received accolades including inclusion in the Global Cleantech 100 and recognition as a Tech Pioneer by the World Economic Forum.

Corlieve Therapeutics SAS is a biotechnology company based in Paris, France, dedicated to developing innovative therapeutic options for patients suffering from severe neurological disorders. The company's primary focus is on addressing temporal lobe epilepsy (TLE) through a gene therapy approach that targets aberrantly expressed kainate receptors in the hippocampus. This lead project is grounded in research from notable institutions, including INSERM, CNRS, Aix Marseille University, and the University of Bordeaux. Established in 2019, Corlieve Therapeutics aims to improve the quality of life for patients with refractory TLE by offering new therapeutic solutions.

Araris Biotech AG is a biotechnology start-up based in Zurich, Switzerland, founded in 2019. The company specializes in developing antibody-drug conjugate (ADC) linker technology aimed at enhancing chemotherapy by delivering drugs directly to targeted antibodies. This innovative approach allows for the creation of next-generation ADCs that are both safe and effective for treating various diseases, including cancer. Araris' platform enables the production of high-quality ADCs without the need for extensive engineering of antibodies or cell lines, allowing for rapid development and manufacturing processes. The technology is supported by two patents and focuses on site-specific conjugation, enabling the use of readily available antibodies. This streamlined production method facilitates quick quality control and analysis, enhancing the overall efficiency and reliability of ADC development.

NativeWaves is focused on enhancing the event viewing experience for audiences worldwide through its innovative audio synchronization and streaming technology. The company collaborates with partners to curate engaging content from live events and develops tools that facilitate personalized viewing experiences. By offering efficient and versatile content delivery solutions, NativeWaves allows for seamless integration into existing workflows without requiring major changes. Its software enables the translation of movies, sports events, and videos into multiple languages while eliminating issues such as buffering and synchronization delays. Additionally, users benefit from real-time access to live statistics and insights on alternate screens, allowing them to enjoy their favorite entertainment in a manner tailored to their preferences.

Vico Therapeutics B.V., founded in 2019 and based in Leiden, the Netherlands, specializes in developing RNA modulating therapies aimed at treating rare neurological disorders. The company's primary focus is on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome. By discovering and delivering innovative therapies, Vico Therapeutics aims to address the unmet medical needs of patients suffering from these severe central nervous system disorders, thereby enhancing treatment options available to medical professionals.

Artiria Medical SA develops innovative micro-actuated devices aimed at treating vascular diseases, particularly in the brain. Founded in 2019 and based in Lausanne, Switzerland, the company focuses on enhancing the precision and control of surgical procedures involving catheters and guidewires. Its technology facilitates micromotion within brain arteries, thereby improving navigation during stroke treatments. By enabling surgeons to perform these complex procedures with greater accuracy, Artiria Medical contributes to better patient outcomes and the potential to save lives.

Doctorly GmbH is a health tech company based in Berlin, Germany, that specializes in a cloud-based practice management platform for healthcare professionals. Founded in 2017, Doctorly offers a comprehensive software-as-a-service solution designed to enhance efficiency and reduce costs for doctors. The platform includes features such as digital booking, video conferencing, electronic health records, and patient health analysis. Additionally, it facilitates seamless integration with other tools and workflows in the healthcare sector, allowing for improved connectivity between doctors and patients. Doctorly aims to drive meaningful change within the healthcare industry by providing innovative digital solutions that streamline practice management.

Agro.Club operates a comprehensive B2B global marketplace focused on the agricultural sector, primarily serving Europe, South America, and North America. The company aims to enhance the grain supply chain by utilizing technology to connect farmers and grain companies, thereby making food supply more secure, efficient, and sustainable. With over 40,000 farmers and thousands of international and domestic grain businesses using its platform, Agro.Club employs analytics to provide market transparency and algorithms to quickly match supply with demand. Its custom-built platform facilitates the entire transaction process, including quality control, logistics, and financing. As a result, Agro.Club has established itself as a unique marketplace in the agricultural industry and has achieved operational profitability.

Sympatient GmbH is a digital therapeutics company based in Hamburg, Germany, that specializes in virtual reality-based psychotherapy solutions for anxiety disorders. Founded in 2017, the company develops medical virtual reality applications aimed at enhancing mental health, particularly in anxiety and stress management. Its flagship products include Otemi, which helps users manage personal stress through various tasks and exercises, and Invirto, an application that provides therapeutic information and strategies for patients to independently treat their anxiety disorders at home. Sympatient also offers a CE-certified medical device for individuals diagnosed with anxiety disorders. By combining technology with traditional therapy methods, Sympatient aims to make mental health treatment more accessible and personalized for patients worldwide.

Accure Therapeutics is a private pharma R&D engine at clinical stage in the CNS field.

Schüttflix GmbH, founded in 2018 and based in Gütersloh, Germany, operates a digital marketplace and delivery platform for bulk construction supplies, including sand, crushed rock, and gravel. The platform serves as a logistics hub for the construction industry, connecting construction companies with suppliers, waste disposal firms, and freight carriers. By facilitating the ordering, tracking, and management of construction materials through its application, Schüttflix aims to minimize downtime and enhance project efficiency for its users.

Planetly is a Berlin-based company that provides software solutions for carbon management, enabling organizations to analyze, reduce, and offset their carbon footprints. The platform offers comprehensive insights into carbon emissions by collecting and processing data from various departments within a business. This analysis helps companies identify effective strategies for reducing emissions in a pragmatic manner. Planetly serves a diverse range of sectors, including banking, insurance, professional services, manufacturing, retail, and information technology. By promoting transparency and actionable strategies, Planetly aims to equip businesses with the tools necessary to fulfill their environmental responsibilities and contribute to addressing the climate crisis.

CALYXHA Biotechnologies GmbH is a biotechnology company founded in 2019 and based in Vienna, Austria. The company focuses on developing innovative therapies aimed at addressing tissue degeneration, which is a primary underlying factor in numerous significant human diseases. Through its research and development efforts, CALYXHA seeks to provide effective solutions to improve health outcomes related to these conditions.

Superscript is a digital insurance broker that caters to a diverse range of businesses, from startups to established companies. It operates a self-serve online platform that allows small and medium-sized enterprises to buy and manage their insurance quickly and efficiently. By utilizing a price comparison tool and offering a flexible monthly subscription model, Superscript streamlines the process of generating quotes and setting up coverage in just a matter of minutes. The company is notable for being the first UK-based InsurTech to become a Lloyd's of London broker, and its tech-specialist brokerage team provides tailored insurance solutions for high-growth and innovative businesses facing complex risks.

Black will fix the insurance industry fundamentally. Black is an insurance platform like Lloyds of London on blockchain without the expense, delays and bureaucracy that they witness today. Insurance business will be generated by local MGAs / Brokers / Agents whose responsibility is designing insurance products for a market, pricing and selling the product and organizing claims handling. Delegating business to local agents makes the Black business model scalable while bringing business decisions closer to end customers.

Motorpharma is focused on developing drug candidates that target motor proteins, with a particular emphasis on treating spasticity. The company provides drug development services aimed at simplifying research processes for healthcare professionals. By distributing enhanced myosin inhibitors, Motorpharma addresses symptoms associated with stroke and aids in the recovery of patients experiencing spasticity. This approach enables healthcare providers to better manage and treat the challenges faced by their patients in the aftermath of a stroke.

Intercontinental Capital is a premier cross-border financial advisory firm.

Motley London Ltd is a jewelry brand based in London, United Kingdom, founded in 2017. The company specializes in designing, manufacturing, and retailing a variety of jewelry items, including earrings, necklaces, rings, bracelets, and charms. Motley London distinguishes itself as a revolutionary e-commerce brand, offering products crafted by some of the world's top jewelry designers. Its offerings are available for purchase online, allowing customers to access unique and high-quality pieces directly from the brand.

Coindirect accelerates African cryptocurrency adoption by building a bridge between the decentralised world of crypto and the centralised world of traditional finance. The Coindirect founding team are from South Africa. We've created an end-to-end crypto trading platform that allows users to buy and sell coins directly on our peer-to-peer marketplace - without having to first convert - at 0% transaction fees using multiple payment methods, from credit card and local bank transfer through to Paypal. Our wallet supports over 40 different coins and altcoins, including ERC-20 coins; while our Exchange platform supports 15 different trading pairs. The promise is that every African, from a first-time buyer to a pro-investor, can easily and securely buy, sell, trade and track their assets in one place. In addition to creating a service for consumers, Coindirect gives other fintech services access to its underlying tech platform via an API. Coindirect is powering the mainstream adoption of cryptocurrency in Africa and across the globe. By bridging the gap between the traditional finance world and the endless possibilities ahead of us, anyone can #OwnThe Future. Visit our website - Coindirect.com

Aleva Neurotherapeutics develops the next generations of implantable Deep Brain Stimulation systems, based on a MEMS technology. Our unique microfabricated devices enable Target Specific Stimulation and optimization of current therapies. They will also permit targeting new areas of the brain and the measurement of neurophysiological activity, translating into faster, more certain surgical placement of electrode leads. The first application will be in Deep Brain Stimulation for indications such as Parkinson's Disease and Essential Tremor. To maximize the value it can capture from its technology, Aleva intends to develop a series of two therapeutic products, while eliminating technological and clinical development risks at each stage. Our first product, directSTIM, an intelligent directional electrode connected to a best-in-class Deep Brain Stimulation system, has successfully completed an acute clinical trial at the Inselspital in Bern, Switzerland. It is currently further developped for a long term use. Aleva has been was founded in 2008 in Lausanne, Switzerland. It has raised 42 MUSD to date from prominent VCs, private investors and a strategic investor. The company is ISO13485 certified.

ImCheck Therapeutics is a biopharmaceutical company based in Marseille, France, that specializes in developing immunotherapeutics aimed at addressing severe unmet medical needs, particularly in the field of immuno-oncology. Founded in 2015, the company focuses on designing and developing immuno-modulatory antibodies that target members of the butyrophilin super-family of checkpoint molecules. These innovative therapies engage γ9δ2 T cells, a specific type of immune cell, to effectively treat various cancers, including breast, gastric, and ovarian cancers, as well as other solid tumors. Through its advanced research and development efforts, ImCheck Therapeutics seeks to provide next-generation immunotherapeutics for patients suffering from immune-related diseases.

Peerbridge Health is a mobile health IT company that seeks to bring independence and precision with remote monitoring capabilities for medical, wellness, and performance-based needs including the monitoring of vital signs, with thoughtful design and a seamless user experience. It has two digital health and fitness pioneering patents for medical-grade monitoring of all vital signs, with other patents pending. The company was founded by Angelo Acquista and is based in New York.

Yonder AG is a Swiss company, founded in 2015 and based in Zurich, that specializes in documentation-as-a-service (DaaS) solutions. The company's primary offering, Yonder Mind, is an application software designed for information management, enabling organizations to create, maintain, and deliver relevant content to users efficiently. Yonder AG also offers services related to document content creation and conversion, helping clients streamline information dissemination through shorter documents and manageable revisions.

NovaGo Therapeutics AG is a biotechnology company based in Schlieren, Switzerland, focused on researching and developing human antibody therapeutics aimed at treating cerebral stroke and spinal cord injuries. The company specializes in creating recombinant human monoclonal antibodies that target Nogo-A, a nerve outgrowth inhibitor, to promote nerve repair and regeneration. NovaGo has established a strategic partnership with Neurimmune Holding AG, which allows access to a unique class of human-derived antibodies with significant therapeutic potential, developed through Neurimmune's Reverse Translational Medicine™ technology platform. Founded in 2015, NovaGo Therapeutics is dedicated to advancing innovative treatments for neurological conditions.

SONECT enables every shop in the neighborhood to act as a “virtual ATM” using just a smartphone or its POS-system. It democratizes the process of cash distribution in order to reduce the “cost of cash”. SONECT is a location-based matchmaking platform that connects those who want to withdraw cash with those who want to deposit cash – typically a local shop owner. It builds a community around local businesses and helps them generate physical leads. Using SONECT: • local shops will not only have less cash to manage at the end of the day but also earn a commission & attract new customers by offering a new service and having access to an additional marketing channel • individuals can avoid an extra trip to the ATM and withdraw money without fees at the click of a button – wherever they are: in a restaurant, a bar, their favorite local shop, … • banks can reduce ATM operation costs & complement their ATM network – or even enter new markets without investing significant capital. On top of that, they can leverage a new revenue channel and get closer to their customers.

Doctify Limited operates an online platform that enables patients to search, compare, and book appointments with a wide range of healthcare specialists, including doctors in various fields such as cardiology, dermatology, and pediatrics. Founded in 2014 and headquartered in London, the platform allows users to filter their searches based on specialties, location, and availability, enhancing the ease of finding suitable medical care. Additionally, Doctify provides healthcare professionals with tools to manage their practices effectively, including features for collecting and displaying reviews, receiving peer recommendations, and minimizing appointment no-shows through automated reminders. The company has expanded into multiple markets and focuses on enhancing the patient experience by facilitating meaningful feedback and insights into healthcare services.

Mytos is focused on creating a fully automated cell manufacturing platform tailored for the biotech sector, specifically targeting the drug development industry. The company's technology employs automation to enhance the production of human cells, facilitating more efficient and adaptable cell culture processes. This innovative approach allows scientists to modify culturing protocols easily, leading to faster progress in cell growth and development. By streamlining these processes, Mytos aims to support pharmaceutical and biotech businesses in their research and production efforts.

medHF performs Human Factors research at Formative and Validation stages of medical device / combination product development.

YoFumo Technologies Inc. is a Denver, Colorado-based company that specializes in manufacturing innovative solutions for the cannabis industry. Established in 2015, it focuses on post-harvest processing and storage technologies, offering products such as Yofumo Pro+, a comprehensive solution for curing, aging, and managing cannabis after trimming, and the Quad System, which addresses post-harvest processing needs. Additionally, YoFumo Pro provides environmental control and monitoring capabilities for cannabis handling. The company's patent-pending technology enables effective decontamination and curation, allowing for antimicrobial treatment and terpene management without the use of harmful chemicals, thereby enhancing product consistency and quality.

The BaseLaunch accelerator supports carefully selected ventures over the course of 15 months and runs in two phases. It provides non-dilutive funding, no strings attached access to its Healthcare Partners, knowledge from highly experienced advisors, as well as a state-of-the-art infrastructure. Furthermore, Baselaunch embeds the ventures deeply within the Basel region, one of Europe’s finest biotech ecosystem. Baselaunch is backed by five industry leaders — Johnson & Johnson Innovation, Novartis Venture Fund, Pfizer, Roche and Roivant Sciences — as well as by other public and private partners.

In a constantly changing society, speed and assertiveness speak louder. Pocket devices help us to make decisions and save us time in choosing the right ones. We're constant updated about our favorite shows, favorite artists, fancy restaurants. The time has come for this to be replicated to our favorite neighborhood, our favorite city, our dream home/property. In an increasingly technological market, we believe in using artificial intelligence to provide an intelligent connection between SELLER and SEEKERS. Thinking this way, CASAFY brings to the market a POWERFUL App, which offers a fast and intelligent connection between both. The right properties for the right customer, at the right time in their lives. All this easily and accessible at the touch of a finger. This puts the real estate market once and for all in the 21st century, meaning no paperwork, making life easier for those who sell, those who intermediate and those who buy. Thus, we can offer a new proposal reaching from A-Z, from the low cost to the high luxury customer. Imagine seeing only what you want, without needing filters or wasting months searching for the ideal property. We do it for you, without you realizing it, because we have a clean interface with no advertisements. We aim to go where the eyes can't, using imagination and innovation to transform the reality of the entire real estate chain, from the construction company, through the intermediation of real estate and brokers, to the person who acquires the property . Casafy is online in Brazil, with over 1.2 million real estate sale and rental offers published!

Spiral Therapeutics, Inc. is a clinical-stage pharmaceutical company based in San Francisco, California, specializing in the development of therapies for inner ear disorders. Founded in 2016, the company focuses on delivering innovative drug therapies that target acute and subacute hearing loss, as well as balance disorders stemming from neurodegenerative, inflammatory, or vascular causes. By utilizing a platform that ensures the right medications are delivered to the appropriate site for the necessary duration, Spiral Therapeutics aims to provide effective treatments for individuals suffering from hearing disorders, ultimately enhancing their quality of life.

CheckYeti is the largest online platform to book activities in 1000+ mountain and beach destinations across Europe - including skiing & snowboarding, rafting & canyoning, mountain biking, paragliding & ballooning, diving & surfing, jet skiing, boat trips and many more. With 12 000+ offers in 16 countries, CheckYeti enables holidaymakers and outdoor enthusiasts to experience summer and winter activities with their ideal guide.

ReBio Technologies is an industrial biotechnology company that specializes in the developing proprietary routes to key commodity platform biochemicals from renewable resources. It also develops tools in biotechnology to elucidate and design new biosynthetic pathways in a range of microbial hosts, for the efficient and cost-effective production of high-value chemicals through fermentation. This, coupled with state-of-the-art polymer technology, provides manufacturing industries with innovative solutions to their raw material requirements. It was founded in 2014 and is headquartered in Cranleigh, Surrey, United Kingdom.

Public is a venture capital firm that supports technology startups aiming to work more deeply with the UK’s public services.

System1 Biosciences, Inc., is a San Francisco-based neurotherapeutics company that employs phenotypic screening to discover novel drugs for complex neurological and psychiatric diseases such as epilepsy, autism, and schizophrenia, disorders for which current discovery techniques have proved least successful. System1 combines cerebral organoid science, systems neuroscience, robotic automation, and advanced data analytics to discover characterizations of disease never before achievable. These “deep phenotypes” are exploited to identify novel therapeutic targets and drug treatments.

Veesion is a company based in Paris, France, that specializes in gesture recognition technology aimed at detecting shoplifting in the retail sector. Founded in 2018, Veesion has developed an intelligent video surveillance software that employs deep learning algorithms to analyze the footage from security cameras in real-time. This technology identifies gestures associated with theft and sends alerts to human operators, who can then confirm the incident and respond appropriately. Veesion's solution integrates seamlessly with existing surveillance systems, providing retailers and distributors with an innovative and ethical means of safeguarding their assets while optimizing the allocation of security personnel.

GotCourts Ltd is a Zurich-based company that develops a software as a service (SaaS) platform dedicated to racquet sports. Founded in 2014, the platform serves as an online community for players, coaches, and court facility operators. It offers various services, including an online booking system for courts and coaches, a social network for connecting players, and tools for finding opponents and tracking progress. GotCourts aims to create the largest global hub for tennis and other racquet sports, facilitating interactions among enthusiasts and enhancing their sporting experience.

Lava Therapeutics B.V. is a biotechnology company based in Utrecht, the Netherlands, founded in 2016. The company specializes in developing proprietary bispecific antibodies aimed at engaging gamma-delta T cells for the treatment of both hematological and solid cancers. Its innovative platform, known as the Gammabody platform, is designed to create next-generation bispecific antibodies that activate the immune system to recognize and eliminate tumor cells. By harnessing the potential of γδ T cells, Lava Therapeutics aims to produce potent, safe, and cost-effective biopharmaceuticals that enhance the body's ability to combat cancer, thereby transforming the landscape of cancer treatment.

Wagz, Inc. is a pet technology company based in Portsmouth, New Hampshire, specializing in smart collars for dogs. Founded in 2015, the company offers the Wagz Collar, which combines GPS tracking, health monitoring, and location enforcement to keep dogs safe and connected with their owners. The collar features an activity monitor that tracks health and behavior, an LED light for visibility, and a high-definition live streaming camera that can be activated remotely or by bark detection. Additionally, Wagz provides the Wagz Serve Smart Feeder, which ensures dogs receive the proper nutrition at designated times, and mobile applications that allow users to manage collar settings, record medical data, and engage with a community of fellow dog owners. Wagz products are available through various resellers in the United States and online, catering to the needs of modern pet owners.

Houst, formerly known as Airsorted, is a short-let host management service founded in 2015 and based in London, U.K. The company provides a comprehensive platform that simplifies the process of listing properties for short-term rentals. Its services include automated property management, pricing optimization, and marketing, along with essential tasks such as cleaning, laundry, and key handling. By streamlining these aspects, Houst aims to enhance rental yields for homeowners while ensuring a hassle-free experience for both hosts and guests. The company is focused on creating a global platform to facilitate easy home-sharing for everyone.

NRx Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing innovative therapeutics for central nervous system disorders and life-threatening pulmonary diseases. The company aims to address critical health challenges by researching and scaling solutions for conditions that often remain untreated. Notably, NRx has announced the commercialization of ZYESAMI (Aviptadil), which targets COVID-related respiratory failure. Additionally, the company is advancing NRX-100/101, a pioneering sequential drug regimen designed for the treatment of bipolar depression in patients experiencing acute suicidal ideation and behavior. In a significant development, NRx was granted exclusive worldwide rights to develop and market the BriLife COVID vaccine by the Government of Israel, further expanding its portfolio in the fight against serious health threats.

Heist Studios Limited is a London-based company that specializes in manufacturing women's tights, aiming to redefine the traditional bodywear market. Founded in 2014, Heist Studios operates primarily online and has quickly gained traction, selling over 100,000 pairs of tights within its first year. The business has experienced significant growth, achieving a month-on-month increase of 25%. Heist Studios has garnered recognition in the fashion industry, with notable endorsements from publications such as Vogue and STYLE magazine, which praised its products for their quality and innovation.

Loma provides search for all the secondhand, rent and repair sites in one click.

Triple Dragon is a financial services provider specializing in facilitating the growth of game and application developers, as well as publishers, through user acquisition loans. The company offers a range of flexible investment products designed to fund marketing campaigns and user acquisition efforts, allowing clients to expand their install base and boost revenue without relinquishing equity. By supporting the financing needs of gaming technology stakeholders, Triple Dragon helps its clients launch and scale their projects effectively, contributing to their overall business growth.

DF Capital builds relationships with manufacturers and provides working capital solutions up and down supply chains. It helps businesses drive their growth with flexible finance products which allow them to match their cash cycle to the lending term.

Vertus Capital provides capital to help facilitate the sale and purchase of advice firms.

UV Light Care, Inc. is a medtech company based in Boston, Massachusetts, established in 2015. The company specializes in ultraviolet light technology, focusing on its applications in disinfection and various medical settings. UV Light Care has developed innovative disinfection solutions targeting vascular access devices and indwelling catheters, addressing critical unmet needs within the medical community. Through its advancements in UV light technology, the company aims to enhance infection control and improve patient outcomes in healthcare environments.

QMES, LLC is a medical equipment distribution company based in Phoenixville, Pennsylvania, that serves hospitals, rehabilitation centers, skilled nursing facilities, and home patients across Pennsylvania, New Jersey, New York, Maryland, and Delaware. Established in 2012, QMES provides a wide range of medical products aimed at enhancing patient independence, including respiratory therapy equipment, mobility aids, wound care supplies, and nutrition services. Additionally, the company offers online bill payment services to help patients manage their medical equipment expenses. By focusing on patient-centered care, QMES integrates various healthcare solutions to meet the diverse needs of its clients.

omicX decided to harness the exponentially growing collective intelligence in bioinformatics and to leverage it to exploit biological Big Data for novel applications in biotechnology, life science, medecine, agriculture and industry. Their fast-growing company has become a trusted leader and global reference in bioinformatics with users from world leading universities, medical institutions, pharmaceutical companies and the biotech industry.

Bricksave is the global real estate investment platform that allows you to invest in properties around the world simply and without complications. Through an exclusive selection of unique properties in the best locations worldwide, such as Miami, London and Paris, among others, Bricksave allows first-time investors to gain access to investment agreements from just $ 1,000, as well as investors experienced, so that they can do it easily, diversify their portfolio and protect their investment. Investors can operate through the Bricksave platform in minutes and benefit from a portion of the rent, as well as the capital gains resulting from the sale of the property. Bricksave is responsible for the continuous management of the property so that investors have nothing to worry about more than enjoying competitive and secure returns.

Frontier Car Group is a Berlin-based startup that operates used automotive marketplaces in emerging market economies, including Nigeria, Mexico, Argentina, Colombia, Chile, Pakistan, and Indonesia. The company aims to enhance the efficiency of buying and selling used cars through a digital marketplace that offers users an instant price quote for their vehicles and facilitates quick inspections to complete sales. By leveraging technology, creating infrastructure, and implementing innovative business models, Frontier Car Group ensures that all stakeholders benefit from the automotive trading process. Additionally, the company is involved in joint ventures with OLX in India and Poland, further expanding its reach and impact in the used car market.

Mavencare Inc. is a home care services provider based in Toronto, Canada, with additional locations in Calgary, Ottawa, and Edmonton. The company offers a comprehensive range of services designed to support seniors in aging at home, including companionship, housekeeping, meal preparation, personal care, specialized nursing care, and support for conditions such as Alzheimer’s, dementia, and Parkinson’s. Founded by individuals who faced challenges in securing quality home care for their own grandparents, Mavencare aims to address the needs of the nearly 90 percent of seniors who wish to remain in their homes as they age. The company leverages technology to enhance caregiver vetting, match clients with appropriate caregivers, and facilitate communication among families and care providers, ensuring that seniors feel connected and well-cared for. By utilizing data and machine learning, Mavencare seeks to identify potential risks and improve the overall quality of home care.

PlayStack is a game publishing company dedicated to supporting developers in realizing their creative visions. Established on the belief that talented developers often need assistance, PlayStack offers a range of services to facilitate their success. These include comprehensive funding, expert publishing guidance, and technological support aimed at building strong gaming audiences and communities. Drawing on years of experience in leading, producing, and publishing successful games, PlayStack provides the necessary resources and knowledge to help developers effectively navigate the journey from concept to global recognition. Through its commitment to fostering innovative games, PlayStack enables creators to approach their projects with confidence and strategic direction.

Homeshift builds a simple online dashboard that lets users see their existing services. They design homes and services from scratch. They provide services in internet, energy, water, and council.

Iproteos is a biotechnology company specializing in the research and development of innovative therapeutic strategies targeting protein-ligand and protein-protein interactions through the use of peptidomimetics. Utilizing its proprietary IPRO technology, Iproteos focuses on discovering therapeutic agents for diseases affecting the central nervous system, including conditions like schizophrenia, epilepsy, and pediatric cancer. The company's expertise in developing third-generation drugs positions it as a valuable partner for organizations seeking to advance their own therapeutic targets. Through its commitment to addressing complex neurological disorders, Iproteos aims to contribute significantly to the field of medicine.

KB Medical SA is a Swiss company that specializes in the design, development, and marketing of robotic assistance systems for the healthcare industry, particularly in spinal surgery. Founded in 2012 and based in Ecublens, Switzerland, the company offers the AQrate robotic system, which assists surgeons during spinal fusion procedures. This technology enhances surgical precision, reduces the risk of complications, and minimizes radiation exposure for the operating room team. By providing a less hazardous work environment, KB Medical aims to improve patient outcomes and quality of life post-surgery while also lowering overall treatment costs. The company’s operations comply with ISO 13485 standards, ensuring quality in the design and manufacture of its robotic systems. In 2017, KB Medical became a subsidiary of Globus Medical, Inc.

Pockit Limited is a fintech company based in London, United Kingdom, founded in 2010. It offers a prepaid MasterCard and an online banking solution aimed at residents, particularly those underserved by traditional banks. Pockit provides customers with the ability to receive wages and benefits directly into their accounts, as well as fund their accounts through various methods, including debit cards and bank transfers. Its mobile application, available on both iPhone and Android, allows users to manage their finances conveniently from anywhere at any time. The service includes functionality for in-store and online purchases, as well as use abroad, and offers cashback saving options.

3Derm Systems, Inc. is a Boston-based company that specializes in 3D dermatology solutions. Founded in 2011, it has developed a handheld skin imager along with cloud-based software that enables users to capture, store, and transmit high-resolution 3D images of the skin to dermatologists. This innovative system allows non-dermatologists to take clinical-quality images remotely, facilitating efficient monitoring of skin conditions, particularly for patients at risk of skin cancer. By enabling images to be reviewed at medical kiosks and other referral sites, 3Derm helps dermatologists manage high patient volumes while reserving in-office visits for those requiring immediate attention. The company's approach aims to reduce healthcare costs, decrease wait times, and enhance access to dermatological care, allowing patients to monitor their skin from home instead of making frequent, often inconvenient, clinic appointments. 3Derm Systems operates as a subsidiary of Digital Diagnostics, Inc. as of August 2020.

Memory is a Norwegian startup that develops tools for a better future of work. Its first product, Timely, is the world's first AI-powered time tracking and planning tool. Memory has recently introduced Dewo, a personal assistant for deep work. Founded in 2013, Memory is based out of Oslo, Norway.

Integrity Implants focuses in developing unique expandable interbody technology. The company's goal is to make the lives of customers better through advances in minimally invasive procedures. Integrity Implants constructs innovative technologies and products that can contribute to the enhancement of patient and hospital outcomes as it pertains to orthopedics and spine. Integrity Implants was founded 2016 and is headquarters Jupiter, Florida.

prettysocial media is a European social media service provider that specializes in helping clients and publishers monetize their social media presence. The company creates advanced content marketing concepts and distributes them across relevant social channels, facilitating brand communication and audience engagement. By leveraging cutting-edge technology and robust business intelligence, prettysocial delivers insights, strategies, and results across various social and digital marketing channels. Its Native Avenue Platform offers a unique technology that allows for the booking of complex content marketing initiatives within a premium publisher network, effectively connecting sophisticated brand advertising with the extensive reach and engagement of numerous local, national, and international newspaper and magazine publishers. This integration of advertising, media, and content production enables users to develop and implement effective content marketing campaigns.

Flyability SA is a Swiss company founded in 2014 and based in Lausanne, specializing in the development and manufacturing of flying robots designed for industrial inspections in inaccessible and confined spaces. The company’s flagship product, Elios, is a collision-tolerant flying robot that allows for safe inspections in complex environments, such as within buildings and urban areas, reducing the need for human presence in hazardous situations. Flyability’s technology addresses critical issues in the rapidly growing drone industry, particularly concerning collision and injury risks. Its applications extend beyond industrial inspections to include search and rescue operations and security assessments, enabling professionals to gather vital data while ensuring safety. The company has received numerous accolades, including the Drones for Good Award, reflecting its commitment to innovation and societal impact.